Stephen Tonna

2.0k total citations
18 papers, 1.3k citations indexed

About

Stephen Tonna is a scholar working on Molecular Biology, Nephrology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stephen Tonna has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Nephrology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stephen Tonna's work include Renal Diseases and Glomerulopathies (9 papers), Axon Guidance and Neuronal Signaling (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Stephen Tonna is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Axon Guidance and Neuronal Signaling (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Stephen Tonna collaborates with scholars based in Australia, United States and China. Stephen Tonna's co-authors include Martin R. Pollak, Judy Savige, Yan Yan Wang, Kesha Rana, Assam El‐Osta, Johannes Schlöndorff, Joel Henderson, Henry N. Higgs, Daniel Becker and Elizabeth Brown and has published in prestigious journals such as Nature Genetics, Development and The FASEB Journal.

In The Last Decade

Stephen Tonna

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Tonna Australia 13 609 603 190 178 156 18 1.3k
Eckhard Schulze-Lohoff Germany 22 475 0.8× 286 0.5× 217 1.1× 88 0.5× 144 0.9× 42 1.4k
Mary Donnelly United Kingdom 10 414 0.7× 709 1.2× 75 0.4× 120 0.7× 123 0.8× 10 1.2k
Berenice Reed United States 20 610 1.0× 324 0.5× 142 0.7× 479 2.7× 39 0.3× 32 1.2k
Laura Giardino Italy 15 654 1.1× 1.0k 1.7× 39 0.2× 242 1.4× 119 0.8× 19 1.6k
Géraldine Mollet France 15 538 0.9× 367 0.6× 200 1.1× 377 2.1× 82 0.5× 24 1.0k
Ivan G. Gomez United States 17 670 1.1× 292 0.5× 99 0.5× 107 0.6× 61 0.4× 26 1.3k
Friedhelm Hildebrandt United States 22 958 1.6× 971 1.6× 128 0.7× 618 3.5× 221 1.4× 44 1.9k
Xiaohe Cai United States 14 356 0.6× 336 0.6× 48 0.3× 110 0.6× 68 0.4× 24 1000
Joan Wither Canada 28 475 0.8× 171 0.3× 65 0.3× 333 1.9× 49 0.3× 108 2.7k
Juan Zhao China 20 308 0.5× 267 0.4× 113 0.6× 71 0.4× 115 0.7× 73 1.0k

Countries citing papers authored by Stephen Tonna

Since Specialization
Citations

This map shows the geographic impact of Stephen Tonna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Tonna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Tonna more than expected).

Fields of papers citing papers by Stephen Tonna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Tonna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Tonna. The network helps show where Stephen Tonna may publish in the future.

Co-authorship network of co-authors of Stephen Tonna

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Tonna. A scholar is included among the top collaborators of Stephen Tonna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Tonna. Stephen Tonna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tonna, Stephen, et al.. (2022). Risk Modeling. 3 indexed citations
2.
Tonna, Stephen, Ingrid J. Poulton, P.W.M. Ho, et al.. (2016). Chondrocytic EphrinB2 promotes cartilage destruction by osteoclasts in endochondral ossification. Development. 143(4). 648–57. 31 indexed citations
3.
Tonna, Stephen, Farzin M. Takyar, Christina Vrahnas, et al.. (2014). EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis. The FASEB Journal. 28(10). 4482–4496. 71 indexed citations
4.
Takyar, Farzin M., Christina Vrahnas, Stephen Tonna, et al.. (2013). EphrinB2 reverse signaling in osteoblasts is required for normal bone material strength and increased bone formation in response to parathyroid hormone (PTH). Journal of Bone and Mineral Research. 28. 1 indexed citations
5.
Tonna, Stephen & Natalie A. Sims. (2013). Talking among Ourselves: Paracrine Control of Bone Formation within the Osteoblast Lineage. Calcified Tissue International. 94(1). 35–45. 25 indexed citations
6.
Takyar, Farzin M., Stephen Tonna, P.W.M. Ho, et al.. (2012). EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. Journal of Bone and Mineral Research. 28(4). 912–925. 83 indexed citations
7.
Pirola, Luciano, Aneta Balcerczyk, Richard W. Tothill, et al.. (2011). Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Research. 21(10). 1601–1615. 162 indexed citations
8.
Genovese, Giulio, Stephen Tonna, Gerald B. Appel, et al.. (2010). A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney International. 78(7). 698–704. 123 indexed citations
9.
Tonna, Stephen, Assam El‐Osta, Mark E. Cooper, & Chris Tikellis. (2010). Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nature Reviews Nephrology. 6(6). 332–341. 112 indexed citations
10.
Brown, Elizabeth, Johannes Schlöndorff, Daniel Becker, et al.. (2009). Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nature Genetics. 42(1). 72–76. 312 indexed citations
11.
Tonna, Stephen, Krishna R. Polu, Gerald B. Appel, et al.. (2008). NPHS2variation in focal and segmental glomerulosclerosis. BMC Nephrology. 9(1). 13–13. 38 indexed citations
12.
Tonna, Stephen, et al.. (2008). The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy. Pediatric Nephrology. 23(12). 2201–2207. 36 indexed citations
13.
Rana, Kesha, Stephen Tonna, Yan Yan Wang, et al.. (2007). Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. Pediatric Nephrology. 22(5). 652–657. 27 indexed citations
14.
Tonna, Stephen, et al.. (2007). Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)?. Pediatric Nephrology. 22(5). 645–651. 5 indexed citations
15.
Tonna, Stephen, Savita Dandapani, Gerald B. Appel, et al.. (2007). Functional genetic variation in aminopeptidase A (ENPEP): Lack of clear association with focal and segmental glomerulosclerosis (FSGS). Gene. 410(1). 44–52. 7 indexed citations
16.
Tonna, Stephen. (2005). The Risks of Thin Basement Membrane Nephropathy. Seminars in Nephrology. 25(3). 171–175. 7 indexed citations
17.
Wang, Yan Yan, et al.. (2004). COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney International. 65(3). 786–790. 53 indexed citations
18.
Savige, Judy, Kesha Rana, Stephen Tonna, et al.. (2003). Thin basement membrane nephropathy. Kidney International. 64(4). 1169–1178. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026